Latest Insider Transactions at Nurix Therapeutics, Inc. (NRIX)
This section provides a real-time view of insider transactions for Nurix Therapeutics, Inc. (NRIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nurix Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nurix Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-17.02%
|
$120,960
$21.73 P/Share
|
|
Dec 02
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+14.54%
|
$5,760
$1.86 P/Share
|
|
Nov 04
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,290
-10.49%
|
$82,250
$25.0 P/Share
|
|
Nov 04
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,290
+9.49%
|
$29,610
$9.57 P/Share
|
|
Nov 01
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,546
-9.51%
|
$85,104
$24.28 P/Share
|
|
Nov 01
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-17.02%
|
$138,240
$24.28 P/Share
|
|
Nov 01
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+14.54%
|
$5,760
$1.86 P/Share
|
|
Oct 30
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,182
-12.96%
|
$100,368
$24.3 P/Share
|
|
Oct 30
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,674
+7.91%
|
-
|
|
Oct 30
2024
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,437
-6.35%
|
$82,488
$24.3 P/Share
|
|
Oct 30
2024
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,957
+5.51%
|
-
|
|
Oct 30
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,368
-5.97%
|
$56,832
$24.3 P/Share
|
|
Oct 30
2024
|
Hans Van Houte Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+7.26%
|
-
|
|
Oct 14
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,290
-11.8%
|
$82,250
$25.0 P/Share
|
|
Oct 14
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,290
+10.55%
|
$29,610
$9.57 P/Share
|
|
Oct 01
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-9.6%
|
$126,720
$22.5 P/Share
|
|
Oct 01
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+15.95%
|
$5,760
$1.86 P/Share
|
|
Sep 03
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,050
-13.56%
|
$226,250
$25.28 P/Share
|
|
Sep 03
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,050
+12.43%
|
$45,250
$5.72 P/Share
|
|
Aug 26
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,870
-28.64%
|
$246,750
$25.01 P/Share
|
|
Aug 26
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,870
+13.44%
|
$49,350
$5.72 P/Share
|
|
Aug 26
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-39.21%
|
$500,000
$25.22 P/Share
|
|
Aug 01
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-9.6%
|
$120,960
$21.79 P/Share
|
|
Aug 01
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+15.95%
|
$5,760
$1.86 P/Share
|
|
Aug 01
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,477
-3.2%
|
$73,017
$21.83 P/Share
|
|
Jul 30
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,490
-4.37%
|
$49,800
$20.67 P/Share
|
|
Jul 30
2024
|
Hans Van Houte Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,636
+5.04%
|
-
|
|
Jul 30
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,920
-10.61%
|
$58,400
$20.67 P/Share
|
|
Jul 30
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,674
+9.29%
|
-
|
|
Jul 30
2024
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,408
-7.02%
|
$68,160
$20.67 P/Share
|
|
Jul 30
2024
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,957
+6.14%
|
-
|
|
Jul 17
2024
|
Lori Anne Kunkel Director |
SELL
Bona fide gift
|
Direct |
54,027
-100.0%
|
-
|
|
Jul 01
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,760
-11.63%
|
$120,960
$21.13 P/Share
|
|
Jul 01
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,760
+18.37%
|
$5,760
$1.86 P/Share
|
|
Jun 20
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-29.27%
|
$400,000
$20.01 P/Share
|
|
Jun 13
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,864
-8.59%
|
$31,688
$17.02 P/Share
|
|
Jun 13
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,864
+7.91%
|
$1,864
$1.86 P/Share
|
|
Jun 12
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,900
-8.74%
|
$32,300
$17.01 P/Share
|
|
Jun 12
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+8.04%
|
$1,900
$1.86 P/Share
|
|
Jun 05
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
400
-1.98%
|
$6,800
$17.0 P/Share
|
|
Jun 05
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.94%
|
$400
$1.86 P/Share
|
|
Jun 03
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,596
-7.45%
|
$27,132
$17.01 P/Share
|
|
Jun 03
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,596
+6.93%
|
$1,596
$1.86 P/Share
|
|
May 02
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,499
-4.87%
|
$41,988
$12.83 P/Share
|
|
Apr 30
2024
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,513
-7.09%
|
$18,156
$12.04 P/Share
|
|
Apr 30
2024
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,924
+8.8%
|
-
|
|
Apr 30
2024
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,007
-4.82%
|
$24,084
$12.04 P/Share
|
|
Apr 30
2024
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,206
+6.04%
|
-
|
|
Apr 30
2024
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,387
-1.89%
|
$16,644
$12.04 P/Share
|
|
Apr 30
2024
|
Hans Van Houte Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,886
+3.28%
|
-
|